CFG
REGN icon

Cooper Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Cooper Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$520K Sell
686
-9
-1% -$6.8K 0.04% 255
2026
Q2 		$433K Sell
695
-263
-27% -$179K 0.04% 285
2026
Q1 		$740K Sell
958
-35
-4% -$26.8K 0.07% 198
2025
Q4 		$766K Sell
993
-47
-5% -$31.9K 0.08% 178
2025
Q3 		$585K Sell
1,040
-87
-8% -$49.2K 0.06% 217
2025
Q2 		$591K Buy
1,127
+369
+49% +$206K 0.07% 219
2025
Q1 		$480K Buy
758
+225
+42% +$155K 0.06% 243
2024
Q4 		$380K Sell
533
-66
-11% -$55.4K 0.05% 269
2024
Q3 		$630K Buy
599
+320
+115% +$356K 0.08% 207
2024
Q2 		$293K Buy
+279
New +$270K 0.04% 304
2022
Q2 		– Sell
-553
Closed -$386K – 279
2022
Q1 		$386K Buy
+553
New +$350K 0.15% 138

Other funds holding REGN

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
SBWIC
Schaper Benz & Wise Investment Counsel Neenah, Wisconsin $1.51B AUM 27.44% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
JC
Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Cooper Financial Group's REGN Position: Q3 2026 in Review

Cooper Financial Group reduced its Regeneron Pharmaceuticals (REGN) stake by 1.3% in Q3 2026, selling an estimated $6.8K and leaving 686 shares worth $520K. The position accounts for 0.04% of the portfolio, ranked #255.

Cooper Financial Group first reported a position in REGN in Q1 2022 and has held it in 11 quarters since. The position peaked at $766K in Q4 2025. 54 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Cooper Financial Group held 686 shares of Regeneron Pharmaceuticals worth $520K as of Q3 2026.
  • Cooper Financial Group sold 9 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $6.8K.
  • Regeneron Pharmaceuticals made up 0.04% of Cooper Financial Group's portfolio in Q3 2026, its #255 holding.
  • Cooper Financial Group first reported a position in Regeneron Pharmaceuticals in Q1 2022 and has held it in 11 quarters since.
  • Cooper Financial Group's Regeneron Pharmaceuticals position peaked at $766K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Cooper Financial Group's 13F filing for Q3 2026, filed 7 Oct 2026.